about
Terminal platelet production is regulated by von Willebrand factorCoagulation factor X interaction with macrophages through its N-glycans protects it from a rapid clearanceA mouse model of severe von Willebrand disease: defects in hemostasis and thrombosisPersistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogenInsights from von Willebrand disease animal modelsTowards standardization of in vivo thrombosis studies in mice.LIM kinase/cofilin dysregulation promotes macrothrombocytopenia in severe von Willebrand disease-type 2B.Soluble Siglec-5 associates to PSGL-1 and displays anti-inflammatory activity.Network-based analysis of omics data: the LEAN methodvon Willebrand factor is a major determinant of ADAMTS-13 decrease during mouse sepsis induced by cecum ligation and puncture.Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B.Accelerated uptake of VWF/platelet complexes in macrophages contributes to VWD type 2B-associated thrombocytopenia.von Willebrand factor mutation promotes thrombocytopathy by inhibiting integrin αIIbβ3.Expression of a structurally constrained von Willebrand factor variant triggers acute thrombotic thrombocytopenic purpura in mice.Apoptotic Platelet Events Are Not Observed in Severe von Willebrand Disease-Type 2B Mutation p.V1316M.Use of a thrombopoietin receptor agonist in von Willebrand disease type 2B (p.V1316M) with severe thrombocytopenia and intracranial hemorrhage.Transient von Willebrand factor-mediated platelet influx stimulates liver regeneration after partial hepatectomy in mice.Models for prediction of factor VIII half-life in severe haemophiliacs: distinct approaches for blood group O and non-O patients.Efficient inhibition of collagen-induced platelet activation and adhesion by LAIR-2, a soluble Ig-like receptor family member.In vivo analysis of the role of O-glycosylations of von Willebrand factor.Molecular and cellular biology of von Willebrand factor.Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient miceVon Willebrand Factor Gene Variants Associate with Herpes simplex Encephalitis.Impaired platelet activation and cAMP homeostasis in MRP4-deficient mice.Potent Thrombolytic Effect of N-Acetylcysteine on Arterial Thrombi.Platelet adhesion receptors and their ligands in mouse models of thrombosis.A Laboratory Phenotype/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease: A New Epidemiologic Picture.A genetically-engineered von Willebrand disease type 2B mouse model displays defects in hemostasis and inflammation.Factor VIII and von Willebrand factor--too sweet for their own good.von Willebrand factor: at the crossroads of bleeding and thrombosis.von Willebrand factor: the old, the new and the unknown.Clearance of von Willebrand factor.Of von Willebrand factor and platelets.von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends.LDL receptor-related protein 1 contributes to the clearance of the activated factor VII-antithrombin complex.von Willebrand factor and inflammation.Identification and characterization of the elusive mutation causing the historical von Willebrand Disease type IIC Miami.Cellular uptake of C4b-binding protein is mediated by heparan sulfate proteoglycans and CD91/LDL receptor-related protein.Increased metastatic potential of tumor cells in von Willebrand factor-deficient mice.In vivo clearance of human protein S in a mouse model: influence of C4b-binding protein and the Heerlen polymorphism.
P50
Q27320100-D222F5E1-DA51-4105-BCF0-41331A9C6650Q28484019-E1090EDE-4D68-4227-A11F-97E69AD65C11Q28586884-FD33F5DE-D0D3-47B9-9159-16FDFC7AAAE0Q28588951-A6BD9E46-2889-49E6-B9FD-DC69870B1348Q28592716-A81FE682-98F1-481F-9147-7A3169703C5CQ30651477-E674DC23-4FE4-4793-AE81-9CAAD5A1B73FQ30819316-999D3371-8677-415F-82D8-C58E2EA5A7C0Q30829904-FCA5C769-8FF0-4A17-909F-001BBA28FC57Q30847234-0875FA8F-F13D-42AA-8802-51519DCBA91FQ33383074-D3362612-03B6-4291-9EA3-D38E48109E44Q33388442-4005881A-4BC3-49A2-BB8A-C1BCB297D6A6Q33409786-A7E45E32-E2F5-4289-8BF8-CD2AB28D8B35Q33411711-6334829C-A8C2-476F-A64F-6C0242CE8CB2Q33414495-A21FC3F2-106F-41B8-B542-01FF4CA9E4D6Q33428249-50F101B1-051E-4337-B694-10F2A5483970Q33437102-C8FDB7B6-C1C9-46FB-8D6B-B43F9A981860Q33439157-A6FD8684-9E98-4AC8-8E76-CF5AA2105A0FQ33496780-BCB9B6B2-682A-465B-92E8-FDDBB4F4CBDCQ33668774-E1AF2EF6-0D2D-4A45-B8D5-C67C7860A93BQ34278082-345662E0-DD33-441E-8B98-8C723FED343BQ34529616-09B9D245-0D4F-4558-B8BB-2A6E9316689CQ35053905-6593565E-760F-41D6-AA3D-12760E4874FBQ36029291-8A14293D-4B87-46B4-B705-B83BFC28FA7DQ36226671-EB65C10E-BDB8-45C6-9F13-0EA3B94D6C88Q36367419-4A297721-DD20-4D68-BAD5-53029F4850AFQ36726052-077FB9CD-BB51-412D-8259-203122CED52AQ36822738-A9ED8882-DD76-4AE1-A31D-5564255A8A09Q36925057-BCB50645-58DE-464F-BF08-E212FE5B3AF7Q37768888-C2F7AECA-2960-4335-89EE-EF5ADF37446FQ38000162-5AA99EAD-56EA-42C3-89B6-5C03F2B5D23BQ38047344-4215318D-84BE-4A71-9E06-15A95769E8CBQ38117738-B5EB431B-9B6E-45DF-9271-3571055B2CB3Q38258281-E5BE03A2-28C5-4211-89D7-22FE38242A19Q38364984-EBB79372-A6C1-4D59-B3D3-9A1E6742463CQ39404392-A90B8F01-5A43-4332-B95A-A0F3CF7F25F7Q39410942-A38C3450-E7DB-4A66-8F9E-7F07473D1BF3Q39655365-086F00A5-6B2F-467E-B0CE-145D9048C4A8Q40014366-AE8C3260-E08D-4098-B7CB-F8DDE3338A30Q40331839-9236BFFA-D1AF-4217-BB7F-96278073E8C6Q40385334-68D5988C-6DC3-4EB0-A400-269740F6FC27
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cecile Denis
@ast
Cecile Denis
@en
Cecile Denis
@es
Cecile Denis
@nl
Cecile Denis
@sl
type
label
Cecile Denis
@ast
Cecile Denis
@en
Cecile Denis
@es
Cecile Denis
@nl
Cecile Denis
@sl
prefLabel
Cecile Denis
@ast
Cecile Denis
@en
Cecile Denis
@es
Cecile Denis
@nl
Cecile Denis
@sl
P1053
A-7649-2011
P106
P21
P31
P3829
P496
0000-0001-5152-9156